Literature DB >> 24692522

Updating the OMERACT filter: discrimination and feasibility.

George Wells1, Dorcas E Beaton, Peter Tugwell, Maarten Boers, John R Kirwan, Clifton O Bingham, Annelies Boonen, Peter Brooks, Philip G Conaghan, Maria-Antonietta D'Agostino, Maxime Dougados, Daniel E Furst, Laure Gossec, Francis Guillemin, Philip Helliwell, Sarah Hewlett, Tore K Kvien, Robert B Landewé, Lyn March, Philip J Mease, Mikkel Ostergaard, Lee Simon, Jasvinder A Singh, Vibeke Strand, Désirée M van der Heijde.   

Abstract

The "Discrimination" part of the OMERACT Filter asks whether a measure discriminates between situations that are of interest. "Feasibility" in the OMERACT Filter encompasses the practical considerations of using an instrument, including its ease of use, time to complete, monetary costs, and interpretability of the question(s) included in the instrument. Both the Discrimination and Reliability parts of the filter have been helpful but were agreed on primarily by consensus of OMERACT participants rather than through explicit evidence-based guidelines. In Filter 2.0 we wanted to improve this definition and provide specific guidance and advice to participants.

Entities:  

Keywords:  DISCRIMINATION; FEASIBILITY; OUTCOME AND PROCESS ASSESSMENT; OUTCOME MEASURES IN RHEUMATOLOGY

Mesh:

Year:  2014        PMID: 24692522      PMCID: PMC4212640          DOI: 10.3899/jrheum.131311

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  15 in total

Review 1.  Minimum clinically important difference: the crock of gold at the end of the rainbow?

Authors:  J R Kirwan
Journal:  J Rheumatol       Date:  2001-02       Impact factor: 4.666

Review 2.  Looking for important change/differences in studies of responsiveness. OMERACT MCID Working Group. Outcome Measures in Rheumatology. Minimal Clinically Important Difference.

Authors:  D E Beaton; C Bombardier; J N Katz; J G Wright; G Wells; M Boers; V Strand; B Shea
Journal:  J Rheumatol       Date:  2001-02       Impact factor: 4.666

Review 3.  Assessing health status and quality-of-life instruments: attributes and review criteria.

Authors:  Neil Aaronson; Jordi Alonso; Audrey Burnam; Kathleen N Lohr; Donald L Patrick; Edward Perrin; Ruth E Stein
Journal:  Qual Life Res       Date:  2002-05       Impact factor: 4.147

4.  The OMERACT filter for Outcome Measures in Rheumatology.

Authors:  M Boers; P Brooks; C V Strand; P Tugwell
Journal:  J Rheumatol       Date:  1998-02       Impact factor: 4.666

5.  Testing minimal clinically important difference: consensus or conundrum?

Authors:  Robert J Gatchel; Tom G Mayer
Journal:  Spine J       Date:  2010-04       Impact factor: 4.166

Review 6.  Minimal clinically important difference, clinical perspective: an opinion.

Authors:  Stephen I Rennard
Journal:  COPD       Date:  2005-03       Impact factor: 2.409

7.  The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study.

Authors:  Lidwine B Mokkink; Caroline B Terwee; Donald L Patrick; Jordi Alonso; Paul W Stratford; Dirk L Knol; Lex M Bouter; Henrica C W de Vet
Journal:  Qual Life Res       Date:  2010-02-19       Impact factor: 4.147

8.  An assessment of the sensibility of a quality-of-life instrument.

Authors:  B H Rowe; A D Oxman
Journal:  Am J Emerg Med       Date:  1993-07       Impact factor: 2.469

9.  Improvement in health-related quality of life in patients with SLE following sustained reductions in anti-dsDNA antibodies.

Authors:  Vibeke Strand; Bruce Crawford
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2005-06       Impact factor: 2.217

10.  Evaluation of the patient acceptable symptom state in a pooled analysis of two multicentre, randomised, double-blind, placebo-controlled studies evaluating lumiracoxib and celecoxib in patients with osteoarthritis.

Authors:  Maxime Dougados; Alan Moore; Shaohua Yu; Xavier Gitton
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

View more
  8 in total

1.  Utilize lung ultrasound B-lines and KL-6 to monitor anti-MDA-5 antibody-positive clinically amyopathic dermatomyositis-associated interstitial lung disease: a case report and literature review.

Authors:  Yukai Wang; Shaoqi Chen; Zhangzhang Lin; Jianqun Lin; Xuezhen Xie; Qisheng Lin; Guangzhou Du; Xiufeng Huang; Marco Matucci-Cerinic; Daniel E Furst
Journal:  Clin Rheumatol       Date:  2019-02-11       Impact factor: 2.980

2.  Report of the GRAPPA-OMERACT Psoriatic Arthritis Working Group from the GRAPPA 2015 Annual Meeting.

Authors:  Ana-Maria Orbai; Philip J Mease; Maarten de Wit; Umut Kalyoncu; Willemina Campbell; William Tillett; Lihi Eder; Musaab Elmamoun; Oliver FitzGerald; Dafna D Gladman; Niti Goel; Laure Gossec; Chris A Lindsay; Ingrid Steinkoenig; Philip S Helliwell; Neil J McHugh; Vibeke Strand; Alexis Ogdie
Journal:  J Rheumatol       Date:  2016-05       Impact factor: 4.666

3.  Reliability of Magnetic Resonance Imaging (MRI) Scoring of the Metatarsophalangeal Joints of the Foot according to the Rheumatoid Arthritis MRI Score.

Authors:  Yousra J Dakkak; Xanthe M E Matthijssen; Désirée van der Heijde; Monique Reijnierse; Annette H M van der Helm-van Mil
Journal:  J Rheumatol       Date:  2019-09-15       Impact factor: 4.666

4.  Defining Skin Ulcers in Systemic Sclerosis: Systematic Literature Review and Proposed World Scleroderma Foundation (WSF) definition.

Authors:  Y A Suliman; C Bruni; S R Johnson; E Praino; M Alemam; N Borazan; L Cometi; B Meyers; D Khanna; Y Allanore; M Baron; T Krieg; A Herrick; A Afonso; O Distler; S Kafaja; C P Denton; M Matucci-Cerinic; D E Furst
Journal:  J Scleroderma Relat Disord       Date:  2017-05-19

5.  Measurement Properties of Aerobic Capacity Measures in Neuromuscular Diseases: A Systematic Review.

Authors:  Tim Veneman; Fieke Sophia Koopman; Joost Daams; Frans Nollet; Eric Lukas Voorn
Journal:  J Rehabil Med       Date:  2022-06-20       Impact factor: 3.959

Review 6.  Core outcome sets for research and clinical practice.

Authors:  Alessandro Chiarotto; Raymond W Ostelo; Dennis C Turk; Rachelle Buchbinder; Maarten Boers
Journal:  Braz J Phys Ther       Date:  2017-03-18       Impact factor: 3.377

7.  Validity of the rheumatoid arthritis MRI score applied to the forefeet using the OMERACT filter: a systematic literature review.

Authors:  Yousra J Dakkak; Désirée M van der Heijde; Monique Reijnierse; Annette H M van der Helm-van Mil
Journal:  RMD Open       Date:  2018-12-05

8.  Computer-Assisted Image Analysis in Assessment of Peripheral Joint MRI in Inflammatory Arthritis: A Systematic Review and Meta-analysis.

Authors:  Arya Haj-Mirzaian; Olga Kubassova; Mikael Boesen; John Carrino; Paul Bird
Journal:  ACR Open Rheumatol       Date:  2022-06-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.